[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Mumps Vaccine Market Report 2016

November 2016 | 95 pages | ID: U705C7A59BAEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Mumps Vaccine

Revenue, means the sales value of Mumps Vaccine

This report studies sales (consumption) of Mumps Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Merck
  • GSK
  • Sanofi-Pasteur
  • China National Biotec Group
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Mumps Vaccine in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Mumps Vaccine Market Report 2016

1 MUMPS VACCINE OVERVIEW

1.1 Product Overview and Scope of Mumps Vaccine
1.2 Classification of Mumps Vaccine
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Mumps Vaccine
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Mumps Vaccine (2011-2021)
  1.4.1 United States Mumps Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Mumps Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES MUMPS VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Mumps Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Mumps Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Mumps Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Mumps Vaccine Market Competitive Situation and Trends
  2.4.1 Mumps Vaccine Market Concentration Rate
  2.4.2 Mumps Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MUMPS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Mumps Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States Mumps Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States Mumps Vaccine Price by Type (2011-2016)
3.4 United States Mumps Vaccine Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MUMPS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Mumps Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States Mumps Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MUMPS VACCINE MANUFACTURERS PROFILES/ANALYSIS

5.1 Merck
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Mumps Vaccine Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Merck Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GSK
  5.2.2 Mumps Vaccine Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GSK Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sanofi-Pasteur
  5.3.2 Mumps Vaccine Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sanofi-Pasteur Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 China National Biotec Group
  5.4.2 Mumps Vaccine Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 China National Biotec Group Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview

6 MUMPS VACCINE MANUFACTURING COST ANALYSIS

6.1 Mumps Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Mumps Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Mumps Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Mumps Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MUMPS VACCINE MARKET FORECAST (2016-2021)

10.1 United States Mumps Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States Mumps Vaccine Sales Forecast by Type (2016-2021)
10.3 United States Mumps Vaccine Sales Forecast by Application (2016-2021)
10.4 Mumps Vaccine Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Mumps Vaccine
Table Classification of Mumps Vaccine
Figure United States Sales Market Share of Mumps Vaccine by Type in 2015
Table Application of Mumps Vaccine
Figure United States Sales Market Share of Mumps Vaccine by Application in 2015
Figure United States Mumps Vaccine Sales and Growth Rate (2011-2021)
Figure United States Mumps Vaccine Revenue and Growth Rate (2011-2021)
Table United States Mumps Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Mumps Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Mumps Vaccine Sales Share by Manufacturers
Figure 2016 Mumps Vaccine Sales Share by Manufacturers
Table United States Mumps Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Mumps Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Mumps Vaccine Revenue Share by Manufacturers
Table 2016 United States Mumps Vaccine Revenue Share by Manufacturers
Table United States Market Mumps Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Mumps Vaccine Average Price of Key Manufacturers in 2015
Figure Mumps Vaccine Market Share of Top 3 Manufacturers
Figure Mumps Vaccine Market Share of Top 5 Manufacturers
Table United States Mumps Vaccine Sales by Type (2011-2016)
Table United States Mumps Vaccine Sales Share by Type (2011-2016)
Figure United States Mumps Vaccine Sales Market Share by Type in 2015
Table United States Mumps Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Mumps Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Mumps Vaccine by Type (2011-2016)
Table United States Mumps Vaccine Price by Type (2011-2016)
Figure United States Mumps Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Mumps Vaccine Sales by Application (2011-2016)
Table United States Mumps Vaccine Sales Market Share by Application (2011-2016)
Figure United States Mumps Vaccine Sales Market Share by Application in 2015
Table United States Mumps Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Mumps Vaccine Sales Growth Rate by Application (2011-2016)
Table Merck Basic Information List
Table Merck Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Mumps Vaccine Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Mumps Vaccine Sales Market Share (2011-2016)
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Pasteur Mumps Vaccine Sales Market Share (2011-2016)
Table China National Biotec Group Basic Information List
Table China National Biotec Group Mumps Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table China National Biotec Group Mumps Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mumps Vaccine
Figure Manufacturing Process Analysis of Mumps Vaccine
Figure Mumps Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Mumps Vaccine Major Manufacturers in 2015
Table Major Buyers of Mumps Vaccine
Table Distributors/Traders List
Figure United States Mumps Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Mumps Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Mumps Vaccine Production Forecast by Type (2016-2021)
Table United States Mumps Vaccine Consumption Forecast by Application (2016-2021)


More Publications